SingleQuotsTM Kit for adipogenic differentiation of mesenchymal stem cells
For efficient transfection of difficult-to-transfect cell lines, e.g. K-562, Neuro-2A or RAW264.7, in the 4D-Nucleofector® X Unit (100 µL format).
Crypreserved ampule of Peripheral Blood Human Natural Killer Cells (CD56 negative immunomagnetic selection) containing ≥ 5 million cells
Cryopreserved Beagle Dog Hepatocytes, Plateable format
Note: This product will be discontinued once current inventory is depleted. Please inquire
Cryopreserved Beagle Dog Hepatocytes, Suspension format, containing > 5 million cells
Note: This product will be discontinued once current inventory is depleted.
Cryopreserved ampule of Normal Human Neonatal Dermal Fibroblasts (NHDF-Neo) containing ≥ 500,000 cells
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
References - X-Vivo™Overview of relevant references
-
X-VIVO Reference Guide 2025A curated list of peer-reviewed articles related to X-VIVO RUO media as used for culturing different primary cells and is a resource for potential consumers to find scientific data.
-
Instructions for Use – TheraPEAK® X-VIVO® Cell Culture MediumInstructions for how to use the X-VIVO® Media Series
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - TheraPEAK® T-VIVO® Cell Culture MediumInstructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
-
A Non-Viral Method for Modifying and Expanding Primary T CellsLearn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
-
Serum-free Media FFM Part Codes2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)